Skip to content
12 May, 2022
Latest News
Bill Gates Says He Has COVID-19, Experiencing Mild Symptoms
WHO Studies Whether COVID-19 Has Role in Child Hepatitis Mystery
Shanghai Tightens Lockdown Despite Falling COVID Cases
  • Home
  • Contact
  • Submit News
  • Sitemap
lesothowire.com
  • Home
  • General
  • Industry
  • Judicial
  • Medicine
  • Arts
  • National
  • Literacy
  • Athletic
  • Press Releases
  • Home
  • National

Category: National

Angolan President attends SADC meeting

April 12, 2022 lwadmin

Luanda – The Angolan Head of State, João Lourenço, on Tuesday took part by video conference in the Summit of the Southern African Development Community (SADC), which addressed the situation in Mozambique.

At the meeting, the SADC leaders assessed the …

National, Politics

SADC approves USD 1.4 million for humanitarian operations centre

March 20, 2022 lwadmin

Luanda – The Southern African Development Community (SADC) on Saturday night approved an amount of around USD 1.4 million for the operation of the Humanitarian Operations Centre (SHOC), based in Nacala, Mozambique.

The amount was approved during the Council of …

National, Politics

Children at Risk of Contracting COVID-19 – NACOSEC

March 17, 2022
Published by
TDPel Media

The National Covid-19 Secretariat (NACOSEC) Chief Executive Officer (CEO) Mr. Thabo Ntoi says children are also at the risk of contracting Covid-19, thus urges parents and guardians to ensure that eligible children from ages 12-17 years …

National

Withdrawal of Peacekeepers Draws Fears of ‘Security Threats’ in Contested Abyei

March 10, 2022 lwadmin

The spokesperson for U.N. peacekeepers in the contested Abyei region says the mission will face huge security challenges if the U.N. withdraws Ethiopian troops from the force as planned.

Ethiopia contributes all 2,000 soldiers in the U.N. Interim Force for …

National

African Union Urges Putin to End Conflict

March 10, 2022 lwadmin

Senegalese President and chair of the African Union Macky Sall has asked Russian President Vladimir Putin to seek a lasting cease-fire in Ukraine. Sall’s talk with Putin comes just a week after Senegal abstained from a U.N. vote to condemn …

National, Politics

Lesotho: Communications Minister Launches Insight Center

March 4, 2022
Published by
TDPel Media

The Minister of Communications Science and Technology, Mr Tšoinyane Rapapa on Thursday officiated the launch of Vodacom Foundation Insight Centre-a library for the blind and visually impaired person worth 2 million. Giving his remarks, Mr Rapapa …

National

Employee sentenced for stealing over R1.6 million from employer

March 3, 2022
Published by
TDPel Media

A 55-year-old employee bit off the metaphorical hand of her employer, 55 times by defrauding the company of R1 601 890-57 over a three-year period. EMPLOYEE MANIPULATED FIGURESPolice spokesperson Warrant Officer Majola Nkohli said Elaine Heuer, …

National

BP Exiting Stake in Russian Oil and Gas Company Rosneft

February 27, 2022 lwadmin

BP said Sunday it is exiting its share in Rosneft, a state-controlled Russian oil and gas company, in reaction to Russia’s invasion of Ukraine.

BP has held a 19.75% stake in Rosneft since 2013. That stake is currently valued at …

National, Politics

US Shifting Global Pandemic Strategy as Vaccine Supply Outstrips Demand

February 24, 2022 lwadmin

With the global vaccine supply exceeding distribution capacity, the Biden administration is acknowledging a need to adjust its pandemic response strategy to address hurdles faced by lower-income countries to vaccinate their citizens.

“It is clear that supply is outstripping demand …

National, Politics

Posts navigation

1 2 … 18 Next

Search

Calender

May 2022
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Apr    

Categories

  • General
  • Industry
  • Judicial
  • Medicine
  • Arts
  • National
  • Literacy
  • Athletic
  • Press Releases

Advertisement

Latest News

Bill Gates Says He Has COVID-19, Experiencing Mild Symptoms

  • 10 May 2022

Microsoft co-founder Bill Gates said Tuesday he has tested positive for COVID-19 and is experiencing mild symptoms.Via Twitter, the billionaire...

WHO Studies Whether COVID-19 Has Role in Child Hepatitis Mystery

  • 10 May 2022

The WHO said Tuesday that 348 probable cases of hepatitis of unknown origin had been identified, as studies into the...

Shanghai Tightens Lockdown Despite Falling COVID Cases

  • 9 May 2022

Authorities in Shanghai have again tightened anti-virus restrictions, just as the city was emerging from a month of strict lockdown...

Rare Cases of COVID Returning Prompt Questions About Pfizer PillAs more doctors prescribe Pfizer’s powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people. But experts say there is still much to be learned about the drug, which was authorized in December for adults at high risk of severe COVID-19 based on a study in which 1,000 adults received the medication. Why do some patients seem to relapse? Doctors have started reporting rare cases of patients whose symptoms return several days after completing Paxlovid’s five-day regimen of pills. That has prompted questions about whether those patients are still contagious and should receive a second course of Paxlovid. Last week, the Food and Drug Administration weighed in. It advised against a second round because there’s little risk of severe disease or hospitalization among patients who relapse. Dr. Michael Charness reported last month on a 71-year-old vaccinated patient who saw his symptoms subside but then return, along with a spike in virus levels nine days into his illness. Charness says Paxlovid remains a highly effective drug, but he wonders if it might be less potent against the current omicron variant. The $500 drug treatment was tested and approved based on its performance against the delta version of the coronavirus. “The ability to clear the virus after it’s suppressed may be different from omicron to delta, especially for vaccinated people,” said Charness, who works for Boston’s VA health system. Could some people just be susceptible to a relapse? Both the FDA and Pfizer point out that 1% to 2% of people in Pfizer’s original study saw their virus levels rebound after 10 days. The rate was about the same among people taking the drug or dummy pills, “so it is unclear at this point that this is related to drug treatment,” the FDA stated. Some experts point to another possibility: The Paxlovid dose isn’t strong enough to fully suppress the virus. Andy Pekosz of Johns Hopkins University worries that could spur mutations that are resistant to the drug. “We should really make sure we’re dosing Paxlovid appropriately because I would hate to lose it right now,” said Pekosz, a virologist. “This is one of the essential tools we have to help us turn the corner on the pandemic.” How well does Paxlovid work in vaccinated people? Pfizer tested Paxlovid in the highest-risk patients: unvaccinated adults with no prior COVID-19 infection and other health problems, such as heart disease and diabetes. The drug reduced their risk of hospitalization and death from 7% to 1%. But that doesn’t reflect the vast majority of Americans today, where 89% of adults have had at least one shot. And roughly 60% of Americans have been infected with the virus at some point. “That’s the population I care about in 2022 because that’s who we’re seeing – vaccinated people with COVID – so do they benefit?” asked Dr. David Boulware, a University of Minnesota researcher and physician. There’s no clear answer yet for vaccinated Americans, who already have a hospitalization rate far below 1%. That may come from a large ongoing Pfizer study that includes high-risk vaccinated people. No results have been published; the study is expected to wrap up in the fall. Pfizer said last year that initial results showed Paxlovid failed to meet the study’s goals of significantly resolving symptoms and reducing hospitalizations. It recently stopped enrolling anyone who’s received a vaccination or booster in the past year, a change Boulware says suggests those patients aren’t benefitting. At a minimum, the preliminary data should be released to federal officials, Boulware said. “If the U.S. government is spending billions of dollars on this medicine, what’s the obligation to release that data so that they can formulate a good policy?” Can Paxlovid be used to help prevent COVID-19 infection? Pfizer recently reported that proactively giving Paxlovid to family members of people infected with COVID-19 didn’t significantly reduce their chances of catching it. But that’s not the end of the story. Pfizer is studying several other potential benefits of early use, including whether Paxlovid reduces the length and severity of COVID-19 among households. “It’s a high bar to protect against infection, but I’d love to see data on how Paxlovid did against severe disease because it may be more effective there,” Pekosz said. Source: Voice of America

  • 9 May 2022

As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number...

As Beijing COVID Outbreak Proves Stubborn, Mass Tests Becoming Routine

  • 8 May 2022

Millions of Beijing residents queued up for another round of COVID-19 tests Sunday as China's capital seeks to trace and...

US Workers Grapple With New Stresses as They Return to Office

  • 8 May 2022

Last summer, Julio Carmona started the process of weaning himself off a fully remote work schedule by showing up to...

Pages

  • Home
  • Contact
  • Submit News
  • Sitemap

Latest News

Bill Gates Says He Has COVID-19, Experiencing Mild Symptoms

May 10, 2022

WHO Studies Whether COVID-19 Has Role in Child Hepatitis Mystery

May 10, 2022

Search

Archive

Copyright © 2021 All rights reserved.
Magazine Plus by WEN Themes